The Vanguard Group, Inc. recently announced the acquisition of new stake in Xperi Inc (NYSE:XPER). The institutional investor has increased its shareholding in the Technology company by 1.52% to 5.42 million shares with purchase of 80966.0 shares. This fresh investment now brings its stake to 12.48% valued currently at $55.97 million. In addition, Rubric Capital Management LP raised its holdings by 0.2 million to 4.04 million shares. And Neuberger Berman Investment Advis has lifted its position by 1.19% or 31808.0 shares – to 2.7 million shares.
With over 0.3 million Xperi Inc (XPER) shares trading Friday and a closing price of $11.02 on the day, the dollar volume was approximately $3.3 million. The shares have shown a negative half year performance of -16.20% and its price on 12/29/23 lost nearly -0.99%. Currently, there are 43.39M common shares owned by the public and among those 42.20M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 17 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 8 of these insider trades were purchases, accounting for 514,217 shares. Insider sales of the common stock occurred on 9 occasions, with total insider shares sold totaling 50,454 shares.
The top 3 mutual fund holders in Xperi Inc are iShares Core S&P Small Cap ETF, John Hancock Small Cap Core Fund, and Vanguard Total Stock Market ETF. iShares Core S&P Small Cap ETF owns 2.89 million shares of the company’s stock, all valued at over $29.78 million. The company bought an additional 1590.0 shares recently to bring their total holdings to about 6.64% of the shares outstanding. Vanguard Total Stock Market ETF now owns shares totaling to 2.77% of the shares outstanding.
Shares of Xperi Inc (NYSE: XPER) opened at $11.14, up $0.01 from a prior closing price of $11.13. However, the script later moved the day high at 11.35, down -0.99%. The company’s stock has a 5-day price change of 3.28% and 11.76% over the past three months. XPER shares are trading 27.99% year to date (YTD), with the 12-month market performance up to 32.61% higher. It has a 12-month low price of $7.91 and touched a high of $13.62 over the same period. XPER has an average intraday trading volume of 476.06K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 5.13%, 13.13%, and 2.45% respectively.
Institutional ownership of Xperi Inc (NYSE: XPER) shares accounts for 93.65% of the company’s 43.39M shares outstanding. Mutual fund holders own 43.03%, while other institutional holders and individual stakeholders account for 50.56% and 2.46% respectively.
It has a market capitalization of $478.16M and a beta (3y monthly) value of 0.68. The earnings-per-share (ttm) stands at -$9.68. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.14% over the week and 4.16% over the month.
Analysts forecast that Xperi Inc (XPER) will achieve an EPS of $0.05 for the current quarter, $0.01 for the next quarter and $0.37 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.02 while analysts give the company a high EPS estimate of $0.17. Comparatively, EPS for the current quarter was $0.08 a year ago. Earnings per share for the fiscal year are expected to decrease by -131.00%, and 578.71% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 5 brokerage firm advisors rate Xperi Inc (XPER) as a “Strong Buy” at a consensus score of 1.60. Specifically, 3 Wall Street analysts polled rate the stock as a buy, while 1 of the 5 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the XPER, a number of firms have released research notes about the stock. Rosenblatt stated their Buy rating for the stock in a research note on June 13, 2023, with the firm’s price target at $15.
